A Clinical study to evaluate the effect of karanjadi churna and eranda taila nabhi puran in kasthartava (primary Dysmenorrhoea)

AN EXPLORATORY CLINICAL STUDY TO EVALUATE THE EFFECT OF KARANJADI CHURNA AND ERANDA TAILA NABHI PURANA IN THE MANAGEMENT OF KASHTARTAVA (PRIMARY DYSMENORRHEA) - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108651

Enrollment

Registered

2026-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Females with chief complaint of pain during menstruation along with any other associated symptoms Females who have regular menstrual cycles of 28-35 days in the last 2 months. Patients with h/o using analgesics during menstruation. Patient willing to give informed consent for the study.

Exclusion criteria

Exclusion criteria: Patients suffering dysmenorrhoea from secondary. 2. Patients suffering from sexually transmitted Infections (STIs). 3. Patients suffering from systemic diseases. 4. Patients having pelvic inflammatory disease.

Design outcomes

Primary

Measure	Time frame
To assess the effect of Karanjadi churna and Eranda Taila Nabhi Purana in Kashtartava (Primary Dysmenorrhea).Timepoint: 60 DAYS	—

Secondary

Measure	Time frame
To identify adverse effect of drugs, if any have & it will be recorded in ADR (Adverse drug reactions) Performa. To find out any complication of Nabhi purana procedure if reported.Timepoint: 60 DAYS	—

Countries

India

Contacts

Public ContactDr NIRMA KUMARI VERMA

PGIA,JODHPUR

dr.ashakp07@gmail.com9995917339

Outcome results